Am J Transplant, Volume 21, Suppl 3 Archives - Page 61 of 139 - ATC Abstracts

2021 American Transplant Congress
Transplant Data Platform – An Augmented Clinical Intelligence Framework
C. Focht, W. Tian, J. Zeng, N. Dzebisashvili, S. Ghosh
CareDx, Brisbane, CA
*Purpose: UNOS, SRTR, USRDS registries are rich in patient baseline data. However, all suffer from data attrition as patients move further out post-transplant or between…
2021 American Transplant Congress
Symptoms on MTSOSD Questionnaire in Pancreas Transplantation Recipients
R. Kaur, S. R. Rizvi, B. H. Smith, C. Reid, S. K. McCrady-Spitzer, W. K. Kremers, P. G. Dean, A. Kukla, M. D. Stegall, Y. C. Kudva
Mayo Clinic, Rochester, MN
*Purpose: We used the Modified transplant symptom Occurrence and symptom distress scale (MTSOSD) to study side-effects of immunosuppression after Pancreas transplantation (PT) for patients with…
2021 American Transplant Congress
Enteric Conversion After Bladder-drained Kidney-pancreas Transplantation
S. Sivan, M. Ortigosa-Goggins, M. Patel, M. Morsi, L. Chen, J. Figueiro, G. Ciancio, G. Burke
Miami Transplant Institute, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, FL
*Purpose: In simultaneous kidney-pancreas transplantation (SPK), bladder (BD) and enteric (ED) are both options for pancreaticoduodenal exocrine drainage. While BD provides good early and long…
2021 American Transplant Congress
Impact of Electronic Donor Referral Technology on Deceased Donor Referrals
B. Boyarsky¹, J. R. DiRito², K. Vanterpool¹, J. Piano³, W. Liu³, J. Hewlett⁴, C. Trahan⁴, D. Segev¹, M. Levan¹, A. Massie¹, P. Niles⁴
¹Johns Hopkins, Baltimore, MD, ²Yale, New Haven, CT, ³Transplant Connect, Santa Monica, CA, ⁴Southwest Transplant Alliance, Dallas, TX
*Purpose: Hospitals likely fail to refer many medically eligible potential deceased donors to OPOs. As such, increasing eligible referrals may increase the donor pool. We…
2021 American Transplant Congress
Summary of the OPTN’s Policy and System Modifications in Response to the COVID-19 Pandemic
A. Wilk, S. Taranto, C. Jett, L. Cartwright
UNOS, Richmond, VA
*Purpose: In April 2020, the OPTN made several policy and system modifications in response to the growing COVID-19 pandemic including updates to candidate lab data,…
2021 American Transplant Congress
Monoclonal Antibodies for Covid-19 in Patients with Solid Organ Transplant Recipients
L. Hasan¹, H. Hardgrave², T. Osborn³, R. Dare¹, L. Burdine⁴, E. Giorgakis⁴, J. Rico¹
¹Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, ²University of Arkansas for Medical Sciences, Little Rock, AR, ³Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, ⁴Transplant surgery, University of Arkansas for Medical Sciences, Little Rock, AR
*Purpose: The FDA has issued Emergency Use Authorization (EUA) for monoclonal antibodies for the treatment of mild to moderate COVID-19 in patients at risk for…
2021 American Transplant Congress
Myeloid Foxo1-β-catenin Axis Regulates Hedgehog/Gli1 Signaling and Controls NLRP3-Mediated Innate Immune Responses in Sterile Inflammatory Liver Injury
D. Xu, C. Li, M. Sheng, Y. Lin, Y. Tian, Y. Zhan, A. J. Coito, R. W. Busuttil, D. G. Farmer, J. W. Kupiec-Weglinski, B. Ke
Surgery, Dumont - UCLA Transplant Center, Los Angeles, CA
*Purpose: Foxo1 plays important roles in cell metabolism, oxidative stress, inflammation, and apoptosis. Activation of Hedgehog/Gli1 signaling regulates cell growth, differentiation, and immune function. However,…
2021 American Transplant Congress
Systematic Screening of Kidney Transplant Patients Points Towards Deficits in Neutralizing Antibody Capacity Against Sars-cov-2
V. Wijtvliet¹, K. K. Ariën², J. Mariën², B. Peeters³, R. Hellemans⁴, A. Massart⁴, S. Van Hees¹, P. Moons⁵, H. Theeten⁶, P. Van Damme⁶, H. Goossens⁷, B. Y. De Winter¹, K. J. Ledeganck¹, D. Abramowicz⁴
¹Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium, ²Department of Biomedical Sciences, Institute of Tropical Medicine and University of Antwerp, Antwerp, Belgium, ³Department of Laboratory Medicine, Antwerp University Hospital, Antwerp, Belgium, ⁴Department of Nephrology and Hypertension, Antwerp University Hospital, Antwerp, Belgium, ⁵Biobank, Antwerp University Hospital, Antwerp, Belgium, ⁶Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium, ⁷Department of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
*Purpose: The majority of kidney transplant recipients (KTR) is able to develop SARS-CoV-2 antibodies (Abs). Little is known about the virus neutralizing capacity of these…
2021 American Transplant Congress
Impact of Advanced Renal Dysfunction on Post-Transplant Outcomes After Living Donor Liver Transplantation in the United States
T. Bittermann¹, N. Kaur², P. L. Abt¹, K. M. Olthoff¹, J. K. Heimbach³, J. Emamaullee²
¹University of Pennsylvania, Philadelphia, PA, ²University of Southern California, Los Angeles, CA, ³Mayo Clinic College of Medicine, Rochester, MN
*Purpose: Survival after living donor liver transplantation (LDLT) in the U.S. is excellent. However, the significance of pre-transplant kidney disease on outcomes after LDLT is…
2021 American Transplant Congress
Evaluation and Experience with Hepatitis C Positive to Negative PancreasTransplantation
B. K. Lindner, B. Thomas, M. Cooper, S. Yi, P. Abrams
Medstar Georgetown University Hospital, Washington, DC
*Purpose: The use of hepatitis C virus (HCV) positive organs for transplant to HCV negative recipients has been reported on and has gained popularity across…